Davis R M Inc. Decreases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Davis R M Inc. cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 23.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,308 shares of the company’s stock after selling 1,040 shares during the quarter. Davis R M Inc.’s holdings in Henry Schein were worth $229,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Daiwa Securities Group Inc. raised its stake in shares of Henry Schein by 5.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock worth $1,141,000 after purchasing an additional 850 shares during the last quarter. Isthmus Partners LLC raised its stake in shares of Henry Schein by 2.8% in the fourth quarter. Isthmus Partners LLC now owns 9,888 shares of the company’s stock worth $684,000 after purchasing an additional 266 shares during the last quarter. Amundi raised its stake in shares of Henry Schein by 12.0% in the fourth quarter. Amundi now owns 736,637 shares of the company’s stock worth $52,345,000 after purchasing an additional 79,056 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Henry Schein by 0.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 86,601 shares of the company’s stock worth $5,993,000 after purchasing an additional 458 shares during the last quarter. Finally, Edgestream Partners L.P. raised its stake in shares of Henry Schein by 119.5% in the fourth quarter. Edgestream Partners L.P. now owns 10,472 shares of the company’s stock worth $725,000 after purchasing an additional 5,702 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Down 4.1 %

Shares of HSIC opened at $69.94 on Thursday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock’s 50 day moving average is $74.77 and its two-hundred day moving average is $72.64. The firm has a market cap of $8.68 billion, a P/E ratio of 28.78, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the business posted $0.66 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group raised their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. UBS Group reduced their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company assumed coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Finally, Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Henry Schein has a consensus rating of “Moderate Buy” and an average price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.